The Bristol-Myers Squibb Company (BMY) revenue growth is 5.6%, which is lower than the industry median of 5.6% and the 5-year historical average of 16.2%.
The Bristol-Myers Squibb Company (BMY) operating income growth is (24.1%), compared to the industry median of 17.2% and the 5-year historical average of 21.1%.
The Bristol-Myers Squibb Company (BMY) EPS growth is N/A, compared to the industry median of (21.3%) and the 5-year historical average of 504.2%.
The Bristol-Myers Squibb Company (BMY) Free Cash Flow growth is 18.1%, compared to the industry median of 18.1% and the 5-year historical average of 21.7%.